Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice

Katharina Slätis1, Mats Gåfvels, Kristina Kannisto

  • 1Unit for Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Insights

Abolishing cholic acid synthesis in ApoE knockout mice reduced atherosclerosis by 50%. This involved lower cholesterol absorption and altered lipoproteins, suggesting bile acid inhibition as a therapeutic strategy for hyperlipidemia.

Area of Science:

  • Biochemistry
  • Cardiovascular Biology
  • Metabolic Diseases

Background:

  • Atherosclerosis is a complex disease influenced by lipid metabolism.
  • Apolipoprotein E (apoE) knockout mice are a model for studying atherosclerosis.
  • Cholic acid (CA) is a primary bile acid involved in lipid digestion and absorption.

Purpose of the Study:

  • To investigate the impact of abrogated cholic acid synthesis on atherosclerosis development.
  • To elucidate the mechanisms linking bile acid synthesis, cholesterol absorption, and lipoprotein metabolism in a mouse model.

Main Methods:

  • Creation of a double-knockout (DKO) mouse model by crossbreeding Cyp8b1 knockout and apoE knockout mice.
  • Cholesterol feeding of DKO and apoE knockout mice for 5 months.
  • Analysis of atherosclerotic plaque development, intestinal cholesterol absorption, plasma lipoproteins, and hepatic lipid metabolism.

Main Results:

  • DKO mice exhibited a 50% reduction in atherosclerotic plaques compared to apoE KO mice.
  • This reduction was associated with decreased intestinal cholesterol absorption and lower apoB-lipoproteins.
  • Enhanced bile acid synthesis, reduced hepatic cholesteryl esters, and decreased ACAT2 activity were observed in DKO mice.

Conclusions:

  • Inhibition of cholic acid synthesis significantly ameliorates atherosclerosis in apoE knockout mice.
  • The protective effect is linked to reduced cholesterol absorption and altered lipoprotein profiles.
  • Targeting bile acid synthesis presents a potential therapeutic avenue for hyperlipidemic conditions and atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Inflammation01:38

Inflammation

Overview